Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
35.56
+2.24 (6.72%)
At close: Feb 24, 2026, 4:00 PM EST
35.56
0.00 (0.00%)
After-hours: Feb 24, 2026, 4:34 PM EST
Oruka Therapeutics Market Cap
Oruka Therapeutics has a market cap or net worth of $1.72 billion as of February 24, 2026. Its market cap has increased by 276.04% in one year.
Market Cap
1.72B
Enterprise Value
1.22B
1-Year Change
276.04%
Ranking
Category
Stock Price
$35.56
Market Cap Chart
Since August 30, 2024, Oruka Therapeutics's market cap has increased from $849.32M to $1.72B, an increase of 102.68%. That is a compound annual growth rate of 60.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 1.61B | 9.93% |
| Dec 31, 2025 | 1.47B | 116.22% |
| Dec 31, 2024 | 678.62M | -20.10% |
| Aug 30, 2024 | 849.32M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MBX Biosciences | 1.64B |
| Nurix Therapeutics | 1.62B |
| Sionna Therapeutics | 1.58B |
| Kodiak Sciences | 1.57B |
| Precigen | 1.55B |
| Enliven Therapeutics | 1.54B |
| Celldex Therapeutics | 1.53B |
| Relay Therapeutics | 1.51B |